ESTRO 2021 Abstract Book

ESTRO 2021 27 - 31 August 2021 ONSITE IN MADRID, SPAIN & ONLINE

Table of contents

SATURDAY 28 AUGUST 2021

Teaching lecture Multidisciplinary research in Europe....................................................................................................................... (abs. 2 - 3) The microbiome: Its role in cancer development and treatment response............................................................. (abs. 4) Breast reconstruction and radiotherapy...................................................................................................................... (abs. 5) Neurocognitive changes following radiotherapy for primary brain tumours..................................................... (abs. 6 - 7) Independent dose calculation and pre-treatment patient specific QA..................................................................... (abs. 8) Diffusion MRI: How to get started................................................................................................................................. (abs. 9) The role of RTT leadership in advancing multi-disciplinary research..................................................................... (abs. 10) New developments In skin cancers treatment: is brachytherapy the new frontier especially for the face?...... (abs. 11) Symposium Education in radiation oncology..........................................................................................................................(abs. 12 - 15) Joint symposium ESTRO-EACR: How does cancer cell metabolism affect the radiation response and vice versa?..................(abs. 16 - 19) Symposium New endpoints for early breast cancer - Less is more?.....................................................................................(abs. 20 - 23) Radiosurgery for central nervous system disorders: Beyond glioblastoma and metastases.......................(abs. 24 - 27) Clinical implementation of in vivo dosimetry.....................................................................................................(abs. 28 - 30) Joint symposium ESTRO-AAPM: A roadmap for the use of quantitative imaging in radiation oncology...................................(abs. 31 - 34) Symposium RTT-led radiomics research..................................................................................................................................(abs. 35 - 37) Debate Prostate cancer: Short treatments by SBRT or brachytherapy?.......................................................................(abs. 38 - 40) Poster highlights Poster Highlights 1: Treatment planning 1.........................................................................................................(abs. 41 - 47) Poster Highlights 2: Head and neck 1.................................................................................................................(abs. 48 - 54) Proffered papers Proffered papers 1: Health services and health economics. ............................................................................(abs. 55 - 60) Proffered Papers 2: Tumour microenvironment................................................................................................(abs. 61 - 66) Proffered papers 3: Breast...................................................................................................................................(abs. 67 - 72) Proffered papers 4: CNS.......................................................................................................................................(abs. 73 - 78) Proffered Papers 5: Applied dosimetry...............................................................................................................(abs. 79 - 84) Proffered Papers 6: Adaptive RT: MR-guided and SBRT....................................................................................(abs. 85 - 90) Proffered Papers 7: Advances in RT imaging and contouring...........................................................................(abs. 91 - 96) Symposium Highlights of WCB 2021. .....................................................................................................................................(abs. 97 - 102)